References
- Soltysova A, Altanerova V, Altaner C. Cancer stem cells. Neoplasma 52(6), 435–440 (2005).
- Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells – perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66(19), 9339–9344 (2006).
- Dick JE. Stem cells: self-renewal writ in blood. Nature 423(6937), 231–233 (2003).
- Frank NY, Schatton T, Frank MH. The therapeutic promise of the cancer stem cell concept. J. Clin. Invest. 120(1), 41–50 (2010).
- Monzani E, Facchetti F, Galmozzi E et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur. J. Cancer 43(5), 935–946 (2007).
- Schatton T, Murphy GF, Frank NY et al. Identification of cells initiating human melanomas. Nature 451(7176), 345–349 (2008).
- Boiko AD, Razorenova OV, van de Rijn M et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466(7302), 133–137 (2010).
- Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 456(7222), 593–598 (2008).
- Quintana E, Shackleton M, Foster HR et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18(5), 510–523 (2010).
- Boonyaratanakornkit JB, Yue L, Strachan LR et al. Selection of tumorigenic melanoma cells using ALDH. J. Invest. Dermatol. 130(12), 2799–2808 (2010).
- Frank NY, Schatton T, Kim S et al. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res. 71(4), 1474–1485 (2011).
- Luo Y, Dallaglio K, Chen Y et al. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells 30(10), 2100–2113 (2012).
- Hess DA, Meyerrose TE, Wirthlin L et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104(6), 1648–1655 (2004).
- Marchitti SA, Orlicky DJ, Brocker C, Vasiliou V. Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues. J. Histochem. Cytochem. 58(9), 765–783 (2010).
- Prasmickaite L, Engesaeter BØ, Skrbo N et al. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS ONE 5(5), e10731 (2010).
- Burger PE, Gupta R, Xiong X et al. High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 27(9), 2220–2228 (2009).
- Marcato P, Dean CA, Giacomantonio CA, Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 10(9), 1378–1384 (2011).
- Marcato P, Dean CA, Pan D et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 29(1), 32–45 (2011).
- Vasiliou V, Thompson DC, Smith C, Fujita M, Chen Y. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem. Biol. Interact. doi:10.1016/j.cbi.2012.10.026 (2012) (Epub ahead of print).